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Evaluation of two ELISA Assay Kits against RT-PCR for diagnosis of Dengue
Virus Infection in a Hospital Setting in Karachi, Pakistan
Erum Khan, Vikram Mehraj, Amna Nasir, Nabil Ahmad Khan, Bushra Billoo, Tariq Moatter, Rumina Hasan
Department of Pathology & Microbiology, Aga Khan University Hospital Stadium Road,  Karachi, Pakistan.
Abstract
Objective: To evaluate two commercially available ELISA-based kits against RT-PCR for the diagnosis of
dengue virus infection in a Tertiary Care center in Karachi.
Methods: During the 2006 Dengue outbreak, sera were collected from patients clinically classified as dengue
fever and graded according to WHO grading. Out of these, 83 samples were selected randomly and analyzed
using two different commercial kits (PanBio versus Calbiotech) and were compared with RT-PCR. Clinical charts
of the inpatients were also reviewed. Statistical significance was considered at P < 0.05.
Results: Clinically, a total of 29 (69%) in-patients were diagnosed with dengue haemorrhagic fever, the
remaining 13 (30.9%) were diagnosed as dengue fever. Diagnostic PCR was positive in 73 (87.9%) of the
total 83 patients. PanBio capture ELISA had a sensitivity of 83.5%. Calbiotech on the other hand, had a
sensitivity of 50.7%. The association of PanBio assay with PCR was found to be statistically significant
(p<0.001).
Conclusion: Although RT-PCR is considered as gold standard for diagnosis of dengue virus infection,
serological methods play important role in diagnosis as they are cost effective and easily available, especially in
dengue endemic countries. Sensitivity and specificity of commercial kits can be variable; therefore evaluation of
commercial ELISA kits is important in local setting (JPMA 59:390; 2009).
Introduction
Rapid and accurate methods for the diagnosis of
dengue fever are important for optimum patient management
and institution of early preventive strategies.1 Viral isolation,
nucleic acid detection and serological tests for detection of
virus specific antibody are currently available for diagnosis of
dengue virus (DEN) infection.2,3 In the developing countries,
due to limited resources, serological analysis by commercially
available kits (ELISA based) is the main stay in diagnosis.4
ELISA has been used to detect acute phase (IgM) and
convalescent phase (IgG) antibodies as well as detection of
DEN antigens. IgM detection by ELISA is by far the most
common test used for establishing serodiagnosis . In keeping
with disease pathogenesis, detection of newly formed DEN
antibodies (IgM) in primary infection is variable and is often
not detectable until after viremia ends or fever subsides.
Similarly IgM production is much lower in secondary DEN
infections.5,6
Examination of paired serum samples is considered
most reliable for establishing sero-diagnosis in primary
infections.7 In clinical practice however, only a single serum
sample is available from a suspected patient for diagnosis.
Thus it is important to know sensitivity and specificity of
commercial serologic tests to diagnose dengue infection in
single serum sample from a febrile/clinically suspected
patient. This information is especially relevant for centers
where other diagnostic options are not available.
In the current study we compared two commercial
ELISA based Kits with RT-PCR for its sensitivity and positive
predictive value to diagnose dengue in a single serum sample
received from suspected dengue patients. In addition clinical
charts of In-patients were also reviewed to correlate
serological results with clinical findings.
Materials and Methods
The study was conducted at Aga Khan University
Hospital (AKUH), a 550-bedded tertiary care center with fully
equipped state of art clinical Microbiology Laboratory located
in the metropolitan city of Karachi, Pakistan. During 2006
dengue fever out break, AKUH received sera of clinically
suspected cases for diagnosis. 83 serum samples were
randomly selected and were analyzed using two different
Commercial kits (PanBio Vs Calbiotech). The results of these
kits were compared with RT-PCR. In addition clinical charts
of the in-patients were also reviewed to compare the results
with the clinical findings.
1) PanBio Capture ELISA:  The PanBio Den Duo
(Cat No: E-DEN01D) assay is a combination kit in a
microtiter plate format that is designed to detect both IgG and
IgM antibodies to DEN in separate reactions by use of capture
method. The assay was performed according to the
manufacturer's instructions. The plates were read using dual
wavelength spectrophotometer with reference filter set
between 600-650nm.  The results were interpreted in the light
of control sera (cut-off calibrators) and index value (PanBio
Unit) was calculated as recommended by manufacturers.
Acute dengue virus infection was defined if patient's sera were
positive for high molar concentration of IgM alone or IgM
with low molar concentration of IgG (<22 PanBio Units). The
serum samples positive for IgG > 22 PanBio Units were
considered as secondary cases as suggested by the
manufacturers. Since Calbiotech assay detects only IgM
antibodies against DEN, we compared the ability of two tests
to provide diagnosis, based solely on IgM results on a single
serum sample received from clinically suspected dengue
infected patients.
2) Calbiotech (Catalog No. DE051M): The
Calbiotech Inc. (Catalog No. DE051M), Dengue virus IgM
ELISA test system is an enzyme linked immunosorbent assay
for the detection of IgM antibodies to dengue virus in human
serum or plasma. Performed according to the manufacturer's
instructions, reading the optical density at dual wavelength
with reference filter of 600-650nm. The antibody Index was
calculated using O.D. value and the cut-off value (Calibrator
OD x Calibrator Factor). Excess IgM antibody, with an
antibody index of >1.1 was considered positive for acute
dengue infection; values from 0.9 to 1.1 were taken as
Borderline positive. Since Calbiotech assay detects only IgM
antibodies against DEN, we compared the ability of two tests
to provide diagnosis, based solely on IgM results on a single
serum sample received from clinically suspected dengue
infected patients.
3) Genotype detection by RT-PCR: Viral RNA was
extracted from 140µl of serum samples using QIAamp viral
RNA mini kit (Qiagen Germany Cat No: 52904) in
accordance with the manufacturer's instructions and finally
RNA was eluted in 50µl of nuclease free water.
Reverse transcription and amplification was done
using the Reverse Enzyme Blend from Abgene ™ Company.
(Reverse-iT™ RTase blend). The first round of the RT-PCR
reaction included the reverse transcription and amplification
using Dengue virus consensus group specific primers
previously described by Lanciotti et al.8The PCR reaction was
performed in Eppendorf Master cycler gradient (Germany)
with thermocycler programmed to incubate for 1h at 47ºC,
94ºC for 2 minutes and then proceed with 45 cycles of
denaturation(94ºC, 30 sec), primer annealing (55ºC, 30sec)
and primer extension (72ºC, 2min) and then final extension
(72º,10 minutes). 
A second round of amplification using the genotype-
specific primers along with consensus primer was performed
using aliquot from first round product. The samples were
subjected to 20cycles of denaturation (94ºC, 2minutes),
primer annealing (55ºC, 30sec) and primer extension (72ºC,
2min) and then final extension at (72ºC, 10minutes). A 10µl
portion of PCR product was subjected to electrophoresis using
1.5% agarose gel containing 0.1µg/ml ethedium bromide in
Tris EDTA buffer. 
4) Clinical History and other Laboratory Tests:
Medical records of all in-patients were reviewed for
demographic, clinical and laboratory data. Patients were
categorized into DF and DHF according to the WHO severity
grading scale2 and as published previously.9 Briefly, DF was
defined as an acute febrile illness along with two or more of
the following manifestations: headache, retro-orbital pain,
myalgia, arthralgia, rash and leucopenia. DHF was defined as
fever or history of acute fever, lasting 2-7 days along with
haemorrhagic tendencies, evidenced by at least one of the
following: petechiae, ecchymoses or purpura, bleeding from
mucosa, gastrointestinal tract, haematemesis or melaena. In
addition, thrombocytopenia with platelet count equal to or less
than 100,000 cells per mm3 and evidence of plasma leakage
due to increased vascular permeability were taken into
account.  These included rise in haematocrit (greater than 20%
above average for age and sex), pleural effusion and/or ascites.
Patients with profound shock along with other features of
DHF were classified as Dengue Shock Syndrome (DSS).
Data Management and Statistical Analysis:
For each of sample included in this study, the
information on hospital medical record number/laboratory
identification number, study identification number, age,
gender, dengue IgM and PCR status was recorded on a register
and subsequently entered in MS-Excel.
The clinical findings for the sub group of in-patients
were recorded from the medical records on a semi-structured
data extraction sheet designed for the study. The sheets were
checked and edited for logical errors and missing information
by trained and experienced medical research officer. The data
was coded and entered in Epidata 3.0 (Odense, Denmark) and
transferred to SPSS 15.0 (SPSS Inc., Chicago, IL, USA) for
statistical analysis. In descriptive analysis mean and standard
deviation of the continuous variables and percentages of the
categorical variables were computed. Chi square and Fisher's
exact tests were used for univariate comparisons where
appropriate. A p value of less than or equal to 0.05 was
considered as statistically significant.
Results
The mean age of the total 83 patients was 30.7 ± 16.2
years, ranging from 2 to72 years with most frequent (28.9%)
age group being 21-30 years. There were 50 males and 33
females with a male to female ratio of 1.5. About 50.6%
(n=42) of patients were severe enough to be hospitalized and
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41(49.4%) were outpatients. Information on clinical and
laboratory characteristics was obtained from all the inpatients.
A total of 29 (69%) inpatients were diagnosed with dengue
haemorrhagic fever and the remaining 13 (30.9%) were
diagnosed with dengue fever. (Table-1)
Among 42 inpatients fever was the most common
symptom (100%) at time of presentation followed by nausea
and vomiting (52.4%), rash (50.0%), diarrhea (19.0%),
haemorrhage (19.0%), myalgia (16.7%) and others.
Thrombocytopenia was the most common laboratory
finding present in 31 (73.8%) patients followed by raised
aspartate aminotransferase (AST) in 26 (61.9%), raised
alanine aminotransferase (ALT) in 24 (57.1%), monocytosis
in 18 (42.9%), leucopenia in 11 (26.2%) and lymphocytosis in
10 (23.8%) patients. (Table-1) 
Diagnostic PCR was positive in 73 (87.9%) of the total
83 patients. Of these 43 (58.9%) were DEN-2 and 30 (41.1%)
were DEN-3. None of the patients was positive for DEN-1 and
DEN-4 and co-infection with DEN-2 and DEN-3 was also not
detected. 
Sixty one (83.6%) of PCR positive samples showed
IgM positivity with PanBio Capture ELISA assay, of these
13 (21.3%) patients had primary infection while 48 (78.7%)
had secondary infection. Among IgM positives cases 51
patients had DEN-2 and while 10 were infected with DEN-
3. PanBio performance was comparable with RT-PCR in all
age groups (Figure) and in patients categorized as DF and
DHF (Table 1).
PanBio capture ELISA had a sensitivity of 83.5%,
specificity of 90.0%, positive predictive value (PPV) of 98.4%
and negative predictive value (NPV) of 42.9%. Calbiotech on
the other hand had a sensitivity of 50.7%, specificity of 60.0%,
PPV of 90.2%, NPV of 14.3%. Overall percent accuracy was
84.3% for PanBio assay and 51.8% for Calbiotech assay
(Table-2).  The association of PanBio assay with PCR was
also statistically significant (p<0.001) while that for
Calbiotech assay was not significant (p=0.738) (Table-2).
Table-3 shows the detail of 36 Calbiotech false
negative patients. Among these, 21 were infected by DEN-2,
15 by DEN-3. Similarly, based on clinical data from in-
patients, 33.3% (n=5) of Calbiotech negative cases were
diagnosed with DF while 10 (66.7%) had DHF. Majority of
the false negative cases had low platelet counts (73.3%),
raised ALT (66.7%) and raised AST (66.7%).
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Table 1: General demographics, clinical features and Laboratory findings of patients with dengue virus infection diagnosed
by different assays at Aga Khan University Hospital, Karachi, Pakistan.
Features Overall n=83 PCR (+) n=73 PanBio (+) n=62 Calbiotech (+) n=41
n (%) n (%) n (%) n (%)
Age  Mean (±SD) 30.7 (16.2) 30.4 (15.4) 30.8 (15.7) 27.0 (13.9)
Gender 
Male 50 (60.2) 44 (60.3) 37 (59.7) 28 (68.3)
Female 33 (39.8) 29 (39.7) 25 (40.3) 13 (31.7)
Patient status
Inpatient 42 (50.6) 36 (49.3) 32 (51.6) 24 (58.5)
Outpatient 41 (49.4) 37 (50.7) 30 (48.4) 17 (41.5)
Dengue severity *
DF 13 (31.0) 10 (27.8) 9 (28.1) 6 (25.0)
DHF 29 (69.0) 26 (72.2) 23 (71.9) 18 (75.0)
Clinical features *
Fever 42 (100.0) 36 (100.0) 32 (100.0) 24 (100.0)
Headache 4 (9.5) 3 (8.3) 2 (6.3) 1 (4.2)
Myalgia 7 (16.7) 7 (19.4) 5 (15.6) 5 (20.8)
Diarrhea 8 (19.0) 7 (19.4) 7 (21.9) 4 (16.7)
Nausea/Vomiting 22 (52.4) 19 (52.8) 17 (53.1) 10 (41.7)
Cough 6 (14.3) 6 (16.7) 6 (18.8) 4 (16.7)
Rash 21 (50.0) 18 (50.0) 16 (50.0) 14 (58.3)
Haemorrhage 8 (19.0) 8 (22.2) 0 (0.0) 6 (25.0)
Ascots 3 (7.1) 3 (8.3) 3 (9.4) 2 (8.3)
Laboratory findings *
Thrombocytopenia 31 (73.8) 28 (66.7) 25 (59.5) 19 (45.2)
Leukopenia 11 (26.2) 9 (21.4) 9 (21.4) 7 (16.7)
Lymphocytosis 10 (23.8) 25 (59.5) 20 (47.6) 15 (35.7)
Monocytosis 18 (42.9) 15 (35.7) 15 (35.7) 14 (33.3)
Raised ALT 24 (57.1) 20 (47.6) 19 (45.2) 16 (38.1)
Raised AST 26 (61.9) 22 (52.4) 21 (50.0) 18 (42.9)
DF= Dengue fever, DHF=, Dengue hemorrhagic fever, DEN-2= Dengue genotype2, DEN-3= dengue genotype3,
ALT= alanine aminotransferase, AST= aspartate aminotransferase.
*Percentages are calculated among inpatients (n=42) only.
Discussion
Dengue virus infection has emerged as a great
challenge for public health, worldwide.A rapid and accurate
method for the diagnosis is important for both the clinician
and the patient. In Pakistan dengue virus infection has been
reported since 1993. Due to non-availability of diagnostic tests
locally, the laboratory diagnosis in the past reports was
performed in the collaborating centers abroad.10,11 The year
2005-2006 however, witnessed an unprecedented increase in
epidemic DHF activity in the country with a large number of
cases being reported from Karachi. In view of immense
pressure to ensure rapid diagnosis, many simple ELISA based
commercial kits were imported at national and local hospital
levels. Although most of these kits have shown to have good
sensitivity and specificity when standardized using paired
sera,12 in clinical practice usually, only single sample is
available to give confirmed diagnosis. Thus it is imperative to
evaluate the performance of commercial kits in less then ideal
situations such as non-availability of paired sera and limited
access to advance molecular techniques such as PCR to
analyze the final results. 
We evaluated two commercially available ELISA
based kits against RT-PCR in a diagnostic laboratory setup.
Dengue virus identification by molecular methods such as RT-
PCR, has higher sensitivity and specificity, and is increasingly
being used for the diagnosis. Various RT-PCR protocols for
dengue virus detection are in practice, however, we utilized
the well known two-step nested RT-PCR protocol developed
by Lanciotti et al,8 having the advantage of detecting and
differentiating four dengue serotypes.
Serological diagnostic methods provide a rapid cost
effective diagnosis and anti-dengue IgM and IgG antibodies
are often found from sera of the patients with acute infection.
However, IgM levels may not be detected in secondary
infections. At the same time, cross reaction between dengue
antibodies and other flaviviral antigens may also occur, and
this complicates the diagnosis, if other flavivirus infections
cannot be ruled out. Despite these limitations, serology is still
a main stay in diagnosis of dengue infections in many dengue
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Table 2: Comparative analysis of ELISA based assays with PCR, for patients presenting with signs and
symptoms suggestive of dengue fever at Aga Khan University Hospital Karachi, Pakistan.
PCR Total % Sens % Spec % NPV % PPV % Acc
Positive n = 73 Negative n = 10
Calbiotech Positive 37 4 41 50.7 60.0 14.3 42.8 51.8
Negative 36 6 42
PanBio Positive 61 1 62 83.5 90 90.2 98.4 84.3
Negative 12 9 21
Sens= Sensitivity, Spec= Specificity, NPV= Negative Predictive Value, PPV= Positive Predictive Value, Acc = Accuracy.
Figure: Distribution according to age and type of diagnostic test used at Aga Khan
University Hospital.
Table 3:  Characteristics of patients labeled as false
negative on Calbiotech ELISA assay, at Aga Khan University
Hospital Karachi, Pakistan.


























+ Information not available for all the patients.
endemic countries. Thus it is imperative to evaluate the
performance of commercial kits in local setting.
Sera from 83 patients with clinical suspicion of
Dengue fever and dengue hemorrhagic fever were analyzed
using RT-PCR and the 2 available ELISA kits. PanBio ELISA
was found to be more sensitive and specific than Calbiotech
ELISA, similar results have also been reported in other studies
as well.13,14 We report statistically significant correlation of
PanBio assay with RT-PCR (p<0.001).  Serological results
obtained from Calbiotech assay, did not show statistically
significant association with RT-PCR (p=0.738). 
When tested by Calbiotech ELISA; 33% of patients
with Dengue fever and 66.7% patients with clinical features
consistent with dengue haemorrhagic fever (DHF) were tested
negative. Similarly, 58.3% patients infected with Den-2 and
41.7% of those infected with Den-3 were tested negative by
this kit. These findings suggest that this assay overall had a
poor negative predictive value (14.3%) and all negative tests
must be reconfirmed by another kit and / or method.  
Although our study has limitation of small sample size,
however, our results have identified need for the re-evaluation
of commercial kits for its performance in less then ideal
situations such as non-availability of paired sera and limited
access to advance molecular techniques such as RT- PCR
before reporting the final results. In addition, clinical
presentation such as fever, rash and nausea/vomiting and other
laboratory tests like thrombocytopenia and raised liver
enzymes should be considered before making the final
diagnosis.
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